EP Patent

EP3496702A1 — Tamper resistant formulation of ephedrine and its derivatives

Assigned to Gruenenthal GmbH · Expires 2019-06-19 · 7y expired

What this patent protects

The invention relates to a pharmaceutical dosage form having a breaking strength of at least 300 N and comprising an ephedrine component selected from the group consisting of ephedrine, pseudoephedrine and the physiologically acceptable salts thereof, wherein the weight content o…

USPTO Abstract

The invention relates to a pharmaceutical dosage form having a breaking strength of at least 300 N and comprising an ephedrine component selected from the group consisting of ephedrine, pseudoephedrine and the physiologically acceptable salts thereof, wherein the weight content of the ephedrine component is within the range of from 0.1 to 60 wt.-%, relative to the total weight of the pharmaceutical dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
EP3496702A1
Jurisdiction
EP
Classification
—
Expires
2019-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Gruenenthal GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.